

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | sarcomere organization (GO:0045214) | 7.75863741 |
| 2 | actin-myosin filament sliding (GO:0033275) | 7.12431375 |
| 3 | muscle filament sliding (GO:0030049) | 7.12431375 |
| 4 | cardiac myofibril assembly (GO:0055003) | 6.99987551 |
| 5 | myofibril assembly (GO:0030239) | 6.84648646 |
| 6 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 6.77080187 |
| 7 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 6.58468110 |
| 8 | regulation of skeletal muscle contraction (GO:0014819) | 6.44356171 |
| 9 | plasma membrane repair (GO:0001778) | 6.41767674 |
| 10 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 6.09080839 |
| 11 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 5.90886089 |
| 12 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 5.90691288 |
| 13 | actin-mediated cell contraction (GO:0070252) | 5.87099540 |
| 14 | cardiac muscle contraction (GO:0060048) | 5.62669370 |
| 15 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 5.59905314 |
| 16 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 5.55247233 |
| 17 | behavioral response to nicotine (GO:0035095) | 5.50689672 |
| 18 | regulation of cell communication by electrical coupling (GO:0010649) | 5.32675840 |
| 19 | regulation of relaxation of muscle (GO:1901077) | 5.22328039 |
| 20 | actomyosin structure organization (GO:0031032) | 5.18505594 |
| 21 | regulation of actin filament-based movement (GO:1903115) | 5.16266269 |
| 22 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 5.09903928 |
| 23 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 5.08821255 |
| 24 | striated muscle contraction (GO:0006941) | 5.03429828 |
| 25 | cardiac muscle cell development (GO:0055013) | 4.89772266 |
| 26 | tricarboxylic acid cycle (GO:0006099) | 4.83423667 |
| 27 | cardiac cell development (GO:0055006) | 4.58886239 |
| 28 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 4.57956675 |
| 29 | actin filament-based movement (GO:0030048) | 4.49534948 |
| 30 | skeletal muscle contraction (GO:0003009) | 4.48562093 |
| 31 | regulation of membrane repolarization (GO:0060306) | 4.43337246 |
| 32 | regulation of sarcomere organization (GO:0060297) | 4.42078430 |
| 33 | cardiac muscle hypertrophy (GO:0003300) | 4.39899054 |
| 34 | ventricular cardiac muscle cell action potential (GO:0086005) | 4.39639132 |
| 35 | adult heart development (GO:0007512) | 4.39033384 |
| 36 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 4.37468092 |
| 37 | regulation of striated muscle contraction (GO:0006942) | 4.36124999 |
| 38 | cardiac muscle tissue morphogenesis (GO:0055008) | 4.34806539 |
| 39 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 4.33827015 |
| 40 | striated muscle hypertrophy (GO:0014897) | 4.26110766 |
| 41 | carnitine shuttle (GO:0006853) | 4.19620297 |
| 42 | heart trabecula formation (GO:0060347) | 4.12300611 |
| 43 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 4.09620152 |
| 44 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 4.05484472 |
| 45 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 4.04486037 |
| 46 | creatine metabolic process (GO:0006600) | 4.00772380 |
| 47 | muscle tissue morphogenesis (GO:0060415) | 3.98925902 |
| 48 | regulation of coenzyme metabolic process (GO:0051196) | 3.97988169 |
| 49 | regulation of cofactor metabolic process (GO:0051193) | 3.97988169 |
| 50 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.81795127 |
| 51 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.81795127 |
| 52 | cell communication involved in cardiac conduction (GO:0086065) | 3.72979786 |
| 53 | cell communication by electrical coupling (GO:0010644) | 3.67676151 |
| 54 | muscle hypertrophy (GO:0014896) | 3.67389380 |
| 55 | regulation of the force of heart contraction (GO:0002026) | 3.66771814 |
| 56 | skeletal muscle adaptation (GO:0043501) | 3.66470508 |
| 57 | muscle contraction (GO:0006936) | 3.65617397 |
| 58 | response to inactivity (GO:0014854) | 3.59739932 |
| 59 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.59737863 |
| 60 | heart contraction (GO:0060047) | 3.59064701 |
| 61 | heart process (GO:0003015) | 3.59064701 |
| 62 | negative regulation of potassium ion transport (GO:0043267) | 3.56748066 |
| 63 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.54239931 |
| 64 | negative regulation of protein localization to cell surface (GO:2000009) | 3.52413315 |
| 65 | regulation of cardiac muscle cell contraction (GO:0086004) | 3.52171877 |
| 66 | positive regulation of cation channel activity (GO:2001259) | 3.49750584 |
| 67 | regulation of cardiac muscle contraction (GO:0055117) | 3.49682799 |
| 68 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.48076112 |
| 69 | fatty acid transmembrane transport (GO:1902001) | 3.47645801 |
| 70 | cardiac muscle cell action potential (GO:0086001) | 3.46251388 |
| 71 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 3.44875861 |
| 72 | neuronal action potential propagation (GO:0019227) | 3.39732193 |
| 73 | muscle system process (GO:0003012) | 3.37493318 |
| 74 | striated muscle adaptation (GO:0014888) | 3.36500522 |
| 75 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 3.35044181 |
| 76 | muscle hypertrophy in response to stress (GO:0003299) | 3.35044181 |
| 77 | cardiac muscle adaptation (GO:0014887) | 3.35044181 |
| 78 | regulation of heart rate (GO:0002027) | 3.29584222 |
| 79 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.28867269 |
| 80 | membrane depolarization during action potential (GO:0086010) | 3.27314555 |
| 81 | regulation of sulfur metabolic process (GO:0042762) | 3.25125587 |
| 82 | striated muscle cell development (GO:0055002) | 3.24441977 |
| 83 | respiratory electron transport chain (GO:0022904) | 3.23130825 |
| 84 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.20897935 |
| 85 | neuronal action potential (GO:0019228) | 3.19371849 |
| 86 | regulation of action potential (GO:0098900) | 3.17754420 |
| 87 | regulation of heart contraction (GO:0008016) | 3.16405735 |
| 88 | cardiac conduction (GO:0061337) | 3.16196448 |
| 89 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 3.16194649 |
| 90 | fucose catabolic process (GO:0019317) | 3.13728856 |
| 91 | L-fucose metabolic process (GO:0042354) | 3.13728856 |
| 92 | L-fucose catabolic process (GO:0042355) | 3.13728856 |
| 93 | electron transport chain (GO:0022900) | 3.12962196 |
| 94 | gamma-aminobutyric acid transport (GO:0015812) | 3.11837295 |
| 95 | relaxation of cardiac muscle (GO:0055119) | 3.10227773 |
| 96 | positive regulation of heart rate (GO:0010460) | 3.09405454 |
| 97 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.08612678 |
| 98 | postsynaptic membrane organization (GO:0001941) | 3.08121803 |
| 99 | glycogen catabolic process (GO:0005980) | 3.07769442 |
| 100 | detection of calcium ion (GO:0005513) | 3.06830904 |
| 101 | NADH metabolic process (GO:0006734) | 3.06629661 |
| 102 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.06454493 |
| 103 | response to muscle activity (GO:0014850) | 3.06366742 |
| 104 | regulation of cation channel activity (GO:2001257) | 3.06186848 |
| 105 | muscle cell cellular homeostasis (GO:0046716) | 3.05693377 |
| 106 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.04758361 |
| 107 | ATP synthesis coupled proton transport (GO:0015986) | 3.04758361 |
| 108 | positive regulation of heart contraction (GO:0045823) | 3.02730566 |
| 109 | kynurenine metabolic process (GO:0070189) | 3.00691875 |
| 110 | detection of light stimulus involved in sensory perception (GO:0050962) | 3.00370293 |
| 111 | detection of light stimulus involved in visual perception (GO:0050908) | 3.00370293 |
| 112 | carnitine transmembrane transport (GO:1902603) | 2.99448535 |
| 113 | regulation of ATP catabolic process (GO:1903289) | 2.99335619 |
| 114 | regulation of ATPase activity (GO:0043462) | 2.99335619 |
| 115 | muscle fiber development (GO:0048747) | 2.98374616 |
| 116 | neuromuscular synaptic transmission (GO:0007274) | 2.92530273 |
| 117 | cellular response to ATP (GO:0071318) | 2.91965698 |
| 118 | synaptic transmission, cholinergic (GO:0007271) | 2.79533609 |
| 119 | positive regulation of sodium ion transmembrane transport (GO:1902307) | 2.75226569 |
| 120 | indole-containing compound catabolic process (GO:0042436) | 2.73170334 |
| 121 | indolalkylamine catabolic process (GO:0046218) | 2.73170334 |
| 122 | tryptophan catabolic process (GO:0006569) | 2.73170334 |
| 123 | action potential (GO:0001508) | 2.72053502 |
| 124 | startle response (GO:0001964) | 2.71246336 |
| 125 | indolalkylamine metabolic process (GO:0006586) | 2.68143443 |
| 126 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.67734755 |
| 127 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.66167557 |
| 128 | behavioral response to ethanol (GO:0048149) | 2.64681887 |
| 129 | cellular ketone body metabolic process (GO:0046950) | 2.63703903 |
| 130 | cAMP catabolic process (GO:0006198) | 2.63614331 |
| 131 | primary amino compound metabolic process (GO:1901160) | 2.61592324 |
| 132 | protein polyglutamylation (GO:0018095) | 2.60770185 |
| 133 | positive regulation of fatty acid oxidation (GO:0046321) | 2.59390175 |
| 134 | serotonin metabolic process (GO:0042428) | 2.56319450 |
| 135 | positive regulation of action potential (GO:0045760) | 2.56236177 |
| 136 | regulation of hippo signaling (GO:0035330) | 2.55388891 |
| 137 | cornea development in camera-type eye (GO:0061303) | 2.54907175 |
| 138 | auditory receptor cell stereocilium organization (GO:0060088) | 2.54790290 |
| 139 | axon ensheathment in central nervous system (GO:0032291) | 2.52416110 |
| 140 | central nervous system myelination (GO:0022010) | 2.52416110 |
| 141 | cyclic nucleotide catabolic process (GO:0009214) | 2.48167552 |
| 142 | transmission of nerve impulse (GO:0019226) | 2.47799139 |
| 143 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.45713756 |
| 144 | nephron tubule morphogenesis (GO:0072078) | 2.44156825 |
| 145 | nephron epithelium morphogenesis (GO:0072088) | 2.44156825 |
| 146 | inner ear receptor stereocilium organization (GO:0060122) | 2.42288606 |
| 147 | somite development (GO:0061053) | 2.39441595 |
| 148 | sulfation (GO:0051923) | 2.38482271 |
| 149 | positive regulation of sodium ion transmembrane transporter activity (GO:2000651) | 2.38384908 |
| 150 | positive regulation of meiosis (GO:0045836) | 2.36015343 |
| 151 | nonmotile primary cilium assembly (GO:0035058) | 2.35844042 |
| 152 | indole-containing compound metabolic process (GO:0042430) | 2.34966458 |
| 153 | ketone body metabolic process (GO:1902224) | 2.33519493 |
| 154 | otic vesicle formation (GO:0030916) | 2.33032129 |
| 155 | negative regulation of reactive oxygen species metabolic process (GO:2000378) | 2.32590722 |
| 156 | negative regulation of mast cell activation (GO:0033004) | 2.32366217 |
| 157 | glycerophospholipid catabolic process (GO:0046475) | 2.30814417 |
| 158 | regulation of neurotransmitter uptake (GO:0051580) | 2.29594351 |
| 159 | regulation of hexokinase activity (GO:1903299) | 2.28681187 |
| 160 | regulation of glucokinase activity (GO:0033131) | 2.28681187 |
| 161 | response to pheromone (GO:0019236) | 2.27977690 |
| 162 | interkinetic nuclear migration (GO:0022027) | 2.27751617 |
| 163 | positive regulation of sodium ion transport (GO:0010765) | 2.27313064 |
| 164 | reflex (GO:0060004) | 2.27064974 |
| 165 | piRNA metabolic process (GO:0034587) | 2.26482118 |
| 166 | retinal cone cell development (GO:0046549) | 2.25484277 |
| 167 | auditory behavior (GO:0031223) | 2.23676485 |
| 168 | spinal cord motor neuron differentiation (GO:0021522) | 2.23586104 |
| 169 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.22902019 |
| 170 | C4-dicarboxylate transport (GO:0015740) | 2.22759757 |
| 171 | kidney morphogenesis (GO:0060993) | 2.22128291 |
| 172 | multicellular organismal signaling (GO:0035637) | 2.21946761 |
| 173 | axoneme assembly (GO:0035082) | 2.20498953 |
| 174 | spinal cord development (GO:0021510) | 2.19341544 |
| 175 | glutamate receptor signaling pathway (GO:0007215) | 2.19273471 |
| 176 | synaptic transmission, glutamatergic (GO:0035249) | 2.18135252 |
| 177 | regulation of rhodopsin mediated signaling pathway (GO:0022400) | 2.18071712 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.01208343 |
| 2 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 3.40594518 |
| 3 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.25149318 |
| 4 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 3.12098307 |
| 5 | VDR_22108803_ChIP-Seq_LS180_Human | 2.76018946 |
| 6 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 2.74522848 |
| 7 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 2.74522848 |
| 8 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.68077103 |
| 9 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.60572799 |
| 10 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.47977095 |
| 11 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.30935009 |
| 12 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.26084855 |
| 13 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.26044120 |
| 14 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.16054294 |
| 15 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.14401069 |
| 16 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.07029187 |
| 17 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.01575886 |
| 18 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.00869517 |
| 19 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.00869517 |
| 20 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.99607961 |
| 21 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.94120380 |
| 22 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.91636589 |
| 23 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.90312859 |
| 24 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.86735930 |
| 25 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.86611875 |
| 26 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.86135861 |
| 27 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.85700460 |
| 28 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.83285176 |
| 29 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.78099619 |
| 30 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.74897775 |
| 31 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.74715730 |
| 32 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.74521833 |
| 33 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.73977062 |
| 34 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.71754089 |
| 35 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.71580300 |
| 36 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.70898702 |
| 37 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.69348972 |
| 38 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.68470709 |
| 39 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.66894467 |
| 40 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.61012773 |
| 41 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.60976204 |
| 42 | P300_19829295_ChIP-Seq_ESCs_Human | 1.59933377 |
| 43 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.59632520 |
| 44 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.56558583 |
| 45 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.56481986 |
| 46 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.54950883 |
| 47 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.53801728 |
| 48 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.52841923 |
| 49 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.51450953 |
| 50 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.50933614 |
| 51 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.49698613 |
| 52 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.49360405 |
| 53 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.49035609 |
| 54 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.47237735 |
| 55 | STAT3_23295773_ChIP-Seq_U87_Human | 1.46425127 |
| 56 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.46222289 |
| 57 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.44165230 |
| 58 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.43294843 |
| 59 | FUS_26573619_Chip-Seq_HEK293_Human | 1.43011365 |
| 60 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.42330664 |
| 61 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.42185419 |
| 62 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.41124522 |
| 63 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.41124522 |
| 64 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.40499627 |
| 65 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.40258066 |
| 66 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.38328826 |
| 67 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.38227683 |
| 68 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.37813831 |
| 69 | EWS_26573619_Chip-Seq_HEK293_Human | 1.36366744 |
| 70 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.36053135 |
| 71 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.35679492 |
| 72 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.34758667 |
| 73 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.34649907 |
| 74 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.33619021 |
| 75 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.32430120 |
| 76 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.32266586 |
| 77 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.31958030 |
| 78 | AR_25329375_ChIP-Seq_VCAP_Human | 1.31166789 |
| 79 | * NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.30554241 |
| 80 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.29608009 |
| 81 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.28442883 |
| 82 | * AR_21572438_ChIP-Seq_LNCaP_Human | 1.28169968 |
| 83 | * CTCF_27219007_Chip-Seq_Bcells_Human | 1.27061630 |
| 84 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.26349714 |
| 85 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.26127680 |
| 86 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.25144014 |
| 87 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.24974885 |
| 88 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.23424806 |
| 89 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.22599928 |
| 90 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.21781074 |
| 91 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.19406936 |
| 92 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.19332267 |
| 93 | KDM2B_26808549_Chip-Seq_K562_Human | 1.18868610 |
| 94 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.18693951 |
| 95 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.18389676 |
| 96 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.17649828 |
| 97 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.16552785 |
| 98 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.15631466 |
| 99 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.15631466 |
| 100 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.15370603 |
| 101 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.14863351 |
| 102 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.14429022 |
| 103 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.12729625 |
| 104 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.10897591 |
| 105 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.09702912 |
| 106 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.09556541 |
| 107 | TP53_16413492_ChIP-PET_HCT116_Human | 1.06872167 |
| 108 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.06830777 |
| 109 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.06417060 |
| 110 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.05807769 |
| 111 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.05444742 |
| 112 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.05332164 |
| 113 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.04584093 |
| 114 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.04049685 |
| 115 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.03575182 |
| 116 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.03436088 |
| 117 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.03316548 |
| 118 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.03119023 |
| 119 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.02972901 |
| 120 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.02627422 |
| 121 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.02627422 |
| 122 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.02242943 |
| 123 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.01927127 |
| 124 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.01759177 |
| 125 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.01205723 |
| 126 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.00734499 |
| 127 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.00476447 |
| 128 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.99617335 |
| 129 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.99492948 |
| 130 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.99166807 |
| 131 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.98593757 |
| 132 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.97739078 |
| 133 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 0.97654014 |
| 134 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.97076405 |
| 135 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.96444268 |
| 136 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.95213557 |
| 137 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.95014763 |
| 138 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.94865712 |
| 139 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.94824925 |
| 140 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.94199846 |
| 141 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.93840516 |
| 142 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 0.93498361 |
| 143 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.93489363 |
| 144 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.93044542 |
| 145 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.92659904 |
| 146 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.92058811 |
| 147 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.92015685 |
| 148 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.91719996 |
| 149 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.91394497 |
| 150 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.90874540 |
| 151 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.90731868 |
| 152 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.89885977 |
| 153 | AR_19668381_ChIP-Seq_PC3_Human | 0.88076724 |
| 154 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.86716173 |
| 155 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.86675140 |
| 156 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.85833049 |
| 157 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.85833049 |
| 158 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.85315374 |
| 159 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.84695390 |
| 160 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.84688506 |
| 161 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.84495578 |
| 162 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.83589411 |
| 163 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.83282421 |
| 164 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.82717330 |
| 165 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.81359413 |
| 166 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.81092365 |
| 167 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.80620553 |
| 168 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.79204821 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002837_dystrophic_cardiac_calcinosis | 5.97009134 |
| 2 | MP0000751_myopathy | 5.38062706 |
| 3 | MP0003646_muscle_fatigue | 5.32801123 |
| 4 | MP0004084_abnormal_cardiac_muscle | 4.61504781 |
| 5 | MP0000749_muscle_degeneration | 4.46811704 |
| 6 | MP0004036_abnormal_muscle_relaxation | 4.01666738 |
| 7 | MP0004215_abnormal_myocardial_fiber | 3.99105860 |
| 8 | MP0004145_abnormal_muscle_electrophysio | 3.78837237 |
| 9 | MP0005330_cardiomyopathy | 3.30491581 |
| 10 | MP0004087_abnormal_muscle_fiber | 3.08728321 |
| 11 | MP0000750_abnormal_muscle_regeneration | 2.85033102 |
| 12 | MP0002106_abnormal_muscle_physiology | 2.81500944 |
| 13 | MP0005620_abnormal_muscle_contractility | 2.72502679 |
| 14 | MP0000747_muscle_weakness | 2.67836536 |
| 15 | MP0002972_abnormal_cardiac_muscle | 2.62632784 |
| 16 | MP0002269_muscular_atrophy | 2.53659405 |
| 17 | MP0004130_abnormal_muscle_cell | 2.52112741 |
| 18 | MP0000759_abnormal_skeletal_muscle | 2.41935143 |
| 19 | MP0003137_abnormal_impulse_conducting | 2.40930669 |
| 20 | MP0004484_altered_response_of | 2.40836237 |
| 21 | MP0001968_abnormal_touch/_nociception | 2.39108521 |
| 22 | MP0005369_muscle_phenotype | 2.36737402 |
| 23 | MP0008775_abnormal_heart_ventricle | 2.18550953 |
| 24 | MP0010630_abnormal_cardiac_muscle | 2.15605919 |
| 25 | MP0000569_abnormal_digit_pigmentation | 2.15580312 |
| 26 | MP0001544_abnormal_cardiovascular_syste | 2.11887420 |
| 27 | MP0005385_cardiovascular_system_phenoty | 2.11887420 |
| 28 | MP0005551_abnormal_eye_electrophysiolog | 2.11633583 |
| 29 | MP0004233_abnormal_muscle_weight | 2.07313167 |
| 30 | MP0002638_abnormal_pupillary_reflex | 2.04167736 |
| 31 | MP0006138_congestive_heart_failure | 1.99136993 |
| 32 | MP0003136_yellow_coat_color | 1.90012989 |
| 33 | MP0004085_abnormal_heartbeat | 1.84617056 |
| 34 | MP0002736_abnormal_nociception_after | 1.83433245 |
| 35 | MP0004142_abnormal_muscle_tone | 1.80707059 |
| 36 | MP0004885_abnormal_endolymph | 1.72698466 |
| 37 | MP0005646_abnormal_pituitary_gland | 1.72097549 |
| 38 | MP0005423_abnormal_somatic_nervous | 1.66731139 |
| 39 | MP0004510_myositis | 1.62728710 |
| 40 | MP0003828_pulmonary_edema | 1.61642155 |
| 41 | MP0001486_abnormal_startle_reflex | 1.61443746 |
| 42 | MP0001986_abnormal_taste_sensitivity | 1.59230605 |
| 43 | MP0006276_abnormal_autonomic_nervous | 1.56303800 |
| 44 | MP0002735_abnormal_chemical_nociception | 1.55773365 |
| 45 | MP0004859_abnormal_synaptic_plasticity | 1.55136807 |
| 46 | MP0002332_abnormal_exercise_endurance | 1.49087566 |
| 47 | MP0002876_abnormal_thyroid_physiology | 1.48380211 |
| 48 | MP0002572_abnormal_emotion/affect_behav | 1.47206831 |
| 49 | MP0003221_abnormal_cardiomyocyte_apopto | 1.46596918 |
| 50 | MP0003195_calcinosis | 1.46245306 |
| 51 | MP0006292_abnormal_olfactory_placode | 1.46207550 |
| 52 | MP0002653_abnormal_ependyma_morphology | 1.40045000 |
| 53 | MP0005666_abnormal_adipose_tissue | 1.39527991 |
| 54 | MP0003950_abnormal_plasma_membrane | 1.38357946 |
| 55 | MP0006036_abnormal_mitochondrial_physio | 1.38202894 |
| 56 | MP0003787_abnormal_imprinting | 1.36695171 |
| 57 | MP0001970_abnormal_pain_threshold | 1.34794852 |
| 58 | MP0002734_abnormal_mechanical_nocicepti | 1.32474283 |
| 59 | MP0002127_abnormal_cardiovascular_syste | 1.32056399 |
| 60 | MP0002102_abnormal_ear_morphology | 1.31882399 |
| 61 | MP0001501_abnormal_sleep_pattern | 1.31696607 |
| 62 | MP0005623_abnormal_meninges_morphology | 1.30629060 |
| 63 | MP0003283_abnormal_digestive_organ | 1.30428511 |
| 64 | MP0002733_abnormal_thermal_nociception | 1.29898028 |
| 65 | MP0008872_abnormal_physiological_respon | 1.29864702 |
| 66 | MP0001485_abnormal_pinna_reflex | 1.29547146 |
| 67 | MP0002108_abnormal_muscle_morphology | 1.29235835 |
| 68 | MP0001502_abnormal_circadian_rhythm | 1.27026164 |
| 69 | MP0000427_abnormal_hair_cycle | 1.25530525 |
| 70 | MP0002557_abnormal_social/conspecific_i | 1.20518767 |
| 71 | MP0006072_abnormal_retinal_apoptosis | 1.17371561 |
| 72 | MP0008877_abnormal_DNA_methylation | 1.16556883 |
| 73 | MP0005253_abnormal_eye_physiology | 1.15945185 |
| 74 | MP0000778_abnormal_nervous_system | 1.14061796 |
| 75 | MP0004133_heterotaxia | 1.13666994 |
| 76 | MP0004185_abnormal_adipocyte_glucose | 1.13647994 |
| 77 | MP0000631_abnormal_neuroendocrine_gland | 1.10879915 |
| 78 | MP0010368_abnormal_lymphatic_system | 1.09693690 |
| 79 | MP0000733_abnormal_muscle_development | 1.09661767 |
| 80 | MP0005670_abnormal_white_adipose | 1.09257584 |
| 81 | MP0003011_delayed_dark_adaptation | 1.07865884 |
| 82 | MP0001984_abnormal_olfaction | 1.07702589 |
| 83 | MP0004270_analgesia | 1.07596223 |
| 84 | MP0005375_adipose_tissue_phenotype | 1.07483740 |
| 85 | MP0000013_abnormal_adipose_tissue | 1.06983977 |
| 86 | MP0005171_absent_coat_pigmentation | 1.04186796 |
| 87 | MP0002234_abnormal_pharynx_morphology | 1.03517633 |
| 88 | MP0003279_aneurysm | 1.03447095 |
| 89 | MP0005174_abnormal_tail_pigmentation | 1.03046583 |
| 90 | MP0002938_white_spotting | 1.02122247 |
| 91 | MP0002160_abnormal_reproductive_system | 1.01351096 |
| 92 | MP0002184_abnormal_innervation | 1.00179635 |
| 93 | MP0000266_abnormal_heart_morphology | 0.98002112 |
| 94 | MP0005165_increased_susceptibility_to | 0.96765712 |
| 95 | MP0005645_abnormal_hypothalamus_physiol | 0.95417380 |
| 96 | MP0000343_altered_response_to | 0.95004937 |
| 97 | MP0002752_abnormal_somatic_nervous | 0.93851404 |
| 98 | MP0003879_abnormal_hair_cell | 0.89254798 |
| 99 | MP0000026_abnormal_inner_ear | 0.88552072 |
| 100 | MP0005195_abnormal_posterior_eye | 0.88278115 |
| 101 | MP0002909_abnormal_adrenal_gland | 0.86953424 |
| 102 | MP0000955_abnormal_spinal_cord | 0.84131941 |
| 103 | MP0004742_abnormal_vestibular_system | 0.83961560 |
| 104 | MP0008438_abnormal_cutaneous_collagen | 0.83894901 |
| 105 | MP0002882_abnormal_neuron_morphology | 0.83838207 |
| 106 | MP0003567_abnormal_fetal_cardiomyocyte | 0.82747838 |
| 107 | MP0004272_abnormal_basement_membrane | 0.81443358 |
| 108 | MP0010386_abnormal_urinary_bladder | 0.80266559 |
| 109 | MP0003119_abnormal_digestive_system | 0.80089846 |
| 110 | MP0000049_abnormal_middle_ear | 0.79279004 |
| 111 | MP0009780_abnormal_chondrocyte_physiolo | 0.78391743 |
| 112 | MP0001963_abnormal_hearing_physiology | 0.77129237 |
| 113 | MP0003880_abnormal_central_pattern | 0.76330141 |
| 114 | MP0000230_abnormal_systemic_arterial | 0.75969560 |
| 115 | MP0004043_abnormal_pH_regulation | 0.75638820 |
| 116 | MP0003635_abnormal_synaptic_transmissio | 0.74755263 |
| 117 | MP0003705_abnormal_hypodermis_morpholog | 0.74696931 |
| 118 | MP0000003_abnormal_adipose_tissue | 0.74507079 |
| 119 | MP0001879_abnormal_lymphatic_vessel | 0.72497437 |
| 120 | MP0005167_abnormal_blood-brain_barrier | 0.71250487 |
| 121 | MP0002128_abnormal_blood_circulation | 0.69223137 |
| 122 | MP0002971_abnormal_brown_adipose | 0.63282674 |
| 123 | MP0005266_abnormal_metabolism | 0.61559370 |
| 124 | MP0006035_abnormal_mitochondrial_morpho | 0.61058152 |
| 125 | MP0002822_catalepsy | 0.60792307 |
| 126 | MP0001440_abnormal_grooming_behavior | 0.60348342 |
| 127 | MP0003045_fibrosis | 0.59463885 |
| 128 | MP0001299_abnormal_eye_distance/ | 0.57945326 |
| 129 | MP0008569_lethality_at_weaning | 0.57608309 |
| 130 | MP0004858_abnormal_nervous_system | 0.56604675 |
| 131 | MP0000767_abnormal_smooth_muscle | 0.53469805 |
| 132 | MP0002064_seizures | 0.53180916 |
| 133 | MP0003566_abnormal_cell_adhesion | 0.52376823 |
| 134 | MP0009745_abnormal_behavioral_response | 0.52206549 |
| 135 | MP0004924_abnormal_behavior | 0.49500567 |
| 136 | MP0005386_behavior/neurological_phenoty | 0.49500567 |
| 137 | MP0002272_abnormal_nervous_system | 0.48699364 |
| 138 | MP0008961_abnormal_basal_metabolism | 0.48620555 |
| 139 | MP0005275_abnormal_skin_tensile | 0.47993467 |
| 140 | MP0002063_abnormal_learning/memory/cond | 0.46935384 |
| 141 | MP0001958_emphysema | 0.46414596 |
| 142 | MP0002925_abnormal_cardiovascular_devel | 0.46169932 |
| 143 | MP0005187_abnormal_penis_morphology | 0.45260932 |
| 144 | MP0005595_abnormal_vascular_smooth | 0.45184876 |
| 145 | MP0003633_abnormal_nervous_system | 0.42541282 |
| 146 | MP0004147_increased_porphyrin_level | 0.42469304 |
| 147 | MP0008874_decreased_physiological_sensi | 0.41798938 |
| 148 | MP0002295_abnormal_pulmonary_circulatio | 0.41567088 |
| 149 | MP0003948_abnormal_gas_homeostasis | 0.37217199 |
| 150 | MP0002078_abnormal_glucose_homeostasis | 0.36820051 |
| 151 | MP0005503_abnormal_tendon_morphology | 0.36730753 |
| 152 | MP0005535_abnormal_body_temperature | 0.36511226 |
| 153 | MP0009046_muscle_twitch | 0.35895978 |
| 154 | MP0002066_abnormal_motor_capabilities/c | 0.35310339 |
| 155 | MP0001614_abnormal_blood_vessel | 0.34786650 |
| 156 | MP0002067_abnormal_sensory_capabilities | 0.34102255 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Calf muscle hypertrophy (HP:0008981) | 6.76711673 |
| 2 | Sudden death (HP:0001699) | 6.72260253 |
| 3 | Exercise-induced myalgia (HP:0003738) | 6.64584608 |
| 4 | Muscle hypertrophy of the lower extremities (HP:0008968) | 6.58578479 |
| 5 | Exercise-induced muscle cramps (HP:0003710) | 6.46322848 |
| 6 | Muscle fiber splitting (HP:0003555) | 5.86926878 |
| 7 | Ventricular tachycardia (HP:0004756) | 5.47706365 |
| 8 | Abnormality of the calf musculature (HP:0001430) | 5.41669907 |
| 9 | Hyporeflexia of lower limbs (HP:0002600) | 5.22683300 |
| 10 | Atrial fibrillation (HP:0005110) | 4.77786153 |
| 11 | EMG: myopathic abnormalities (HP:0003458) | 4.74925770 |
| 12 | Myoglobinuria (HP:0002913) | 4.69500715 |
| 13 | Muscle fiber inclusion bodies (HP:0100299) | 4.60660710 |
| 14 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 4.54172217 |
| 15 | Abnormality of the left ventricular outflow tract (HP:0011103) | 4.49192805 |
| 16 | Subaortic stenosis (HP:0001682) | 4.49192805 |
| 17 | Primary atrial arrhythmia (HP:0001692) | 4.48784337 |
| 18 | Difficulty running (HP:0009046) | 4.42457990 |
| 19 | Increased connective tissue (HP:0009025) | 4.36290701 |
| 20 | Supraventricular tachycardia (HP:0004755) | 4.31270895 |
| 21 | Supraventricular arrhythmia (HP:0005115) | 4.24623687 |
| 22 | Bundle branch block (HP:0011710) | 4.15009196 |
| 23 | Lipoatrophy (HP:0100578) | 4.14158380 |
| 24 | Type 1 muscle fiber predominance (HP:0003803) | 4.10954802 |
| 25 | Congenital stationary night blindness (HP:0007642) | 4.06890232 |
| 26 | Myotonia (HP:0002486) | 3.94032305 |
| 27 | Pancreatic cysts (HP:0001737) | 3.86198114 |
| 28 | Nemaline bodies (HP:0003798) | 3.85212483 |
| 29 | Asymmetric septal hypertrophy (HP:0001670) | 3.81018178 |
| 30 | Right ventricular cardiomyopathy (HP:0011663) | 3.77922324 |
| 31 | Syncope (HP:0001279) | 3.73039121 |
| 32 | Abnormality of midbrain morphology (HP:0002418) | 3.64796634 |
| 33 | Molar tooth sign on MRI (HP:0002419) | 3.64796634 |
| 34 | Pancreatic fibrosis (HP:0100732) | 3.64184156 |
| 35 | Difficulty climbing stairs (HP:0003551) | 3.54009550 |
| 36 | Dilated cardiomyopathy (HP:0001644) | 3.52804104 |
| 37 | Prolonged QT interval (HP:0001657) | 3.47700709 |
| 38 | True hermaphroditism (HP:0010459) | 3.46172018 |
| 39 | Rhabdomyolysis (HP:0003201) | 3.42802673 |
| 40 | Nephronophthisis (HP:0000090) | 3.42758665 |
| 41 | Genetic anticipation (HP:0003743) | 3.42411068 |
| 42 | Hyperventilation (HP:0002883) | 3.37970890 |
| 43 | Increased variability in muscle fiber diameter (HP:0003557) | 3.28921735 |
| 44 | Heart block (HP:0012722) | 3.27513523 |
| 45 | Palpitations (HP:0001962) | 3.26649500 |
| 46 | Ventricular arrhythmia (HP:0004308) | 3.23223324 |
| 47 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.18343657 |
| 48 | Abnormal atrioventricular conduction (HP:0005150) | 3.10952870 |
| 49 | Type II lissencephaly (HP:0007260) | 3.09575131 |
| 50 | Muscle stiffness (HP:0003552) | 3.08057823 |
| 51 | Round ear (HP:0100830) | 3.02930301 |
| 52 | Distal arthrogryposis (HP:0005684) | 3.02326556 |
| 53 | Progressive cerebellar ataxia (HP:0002073) | 3.01477671 |
| 54 | Abnormality of the renal medulla (HP:0100957) | 2.97415518 |
| 55 | Abnormality of the renal cortex (HP:0011035) | 2.94542360 |
| 56 | Ventricular fibrillation (HP:0001663) | 2.94082374 |
| 57 | Atrioventricular block (HP:0001678) | 2.92735875 |
| 58 | Abnormality of alanine metabolism (HP:0010916) | 2.90128231 |
| 59 | Hyperalaninemia (HP:0003348) | 2.90128231 |
| 60 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.90128231 |
| 61 | Neck muscle weakness (HP:0000467) | 2.84376719 |
| 62 | Attenuation of retinal blood vessels (HP:0007843) | 2.73315240 |
| 63 | Tubular atrophy (HP:0000092) | 2.68359641 |
| 64 | Cystic liver disease (HP:0006706) | 2.67594042 |
| 65 | Distal lower limb muscle weakness (HP:0009053) | 2.66213821 |
| 66 | Abnormal EKG (HP:0003115) | 2.61654471 |
| 67 | Limb-girdle muscle atrophy (HP:0003797) | 2.61245726 |
| 68 | Gaze-evoked nystagmus (HP:0000640) | 2.60491494 |
| 69 | Myopathic facies (HP:0002058) | 2.60450457 |
| 70 | Febrile seizures (HP:0002373) | 2.59813389 |
| 71 | Increased corneal curvature (HP:0100692) | 2.57321557 |
| 72 | Keratoconus (HP:0000563) | 2.57321557 |
| 73 | Abnormal drinking behavior (HP:0030082) | 2.55137275 |
| 74 | Polydipsia (HP:0001959) | 2.55137275 |
| 75 | Areflexia of lower limbs (HP:0002522) | 2.54288224 |
| 76 | Left ventricular hypertrophy (HP:0001712) | 2.51213628 |
| 77 | Distal lower limb amyotrophy (HP:0008944) | 2.47880987 |
| 78 | Rimmed vacuoles (HP:0003805) | 2.47761327 |
| 79 | Pendular nystagmus (HP:0012043) | 2.45436481 |
| 80 | Focal seizures (HP:0007359) | 2.44349534 |
| 81 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.44128178 |
| 82 | Focal motor seizures (HP:0011153) | 2.44097094 |
| 83 | Broad-based gait (HP:0002136) | 2.37156723 |
| 84 | Chorioretinal atrophy (HP:0000533) | 2.36904597 |
| 85 | Scapular winging (HP:0003691) | 2.36040415 |
| 86 | Testicular atrophy (HP:0000029) | 2.35620883 |
| 87 | Muscular dystrophy (HP:0003560) | 2.34466603 |
| 88 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.34005066 |
| 89 | Gowers sign (HP:0003391) | 2.33941561 |
| 90 | Medial flaring of the eyebrow (HP:0010747) | 2.33107691 |
| 91 | Acute necrotizing encephalopathy (HP:0006965) | 2.32958238 |
| 92 | Chronic hepatic failure (HP:0100626) | 2.30767756 |
| 93 | Hemiparesis (HP:0001269) | 2.29028246 |
| 94 | EMG: neuropathic changes (HP:0003445) | 2.20590696 |
| 95 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.19468901 |
| 96 | Cerebellar dysplasia (HP:0007033) | 2.19314934 |
| 97 | Sclerocornea (HP:0000647) | 2.19260341 |
| 98 | Abolished electroretinogram (ERG) (HP:0000550) | 2.19092856 |
| 99 | Protruding tongue (HP:0010808) | 2.15357580 |
| 100 | Abnormality of the foot musculature (HP:0001436) | 2.14807085 |
| 101 | Clumsiness (HP:0002312) | 2.13431727 |
| 102 | Foot dorsiflexor weakness (HP:0009027) | 2.13218525 |
| 103 | Inability to walk (HP:0002540) | 2.12750794 |
| 104 | Hypoplastic ischia (HP:0003175) | 2.12541827 |
| 105 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.12184751 |
| 106 | Lissencephaly (HP:0001339) | 2.10624517 |
| 107 | Proximal amyotrophy (HP:0007126) | 2.10180313 |
| 108 | Lower limb amyotrophy (HP:0007210) | 2.09576323 |
| 109 | Frequent falls (HP:0002359) | 2.08644967 |
| 110 | Decreased central vision (HP:0007663) | 2.07963363 |
| 111 | Generalized muscle weakness (HP:0003324) | 2.06907529 |
| 112 | Pheochromocytoma (HP:0002666) | 2.05526327 |
| 113 | Spinal rigidity (HP:0003306) | 2.04866994 |
| 114 | Ulnar deviation of the wrist (HP:0003049) | 2.04354795 |
| 115 | Severe muscular hypotonia (HP:0006829) | 2.03220901 |
| 116 | Limb-girdle muscle weakness (HP:0003325) | 2.02442632 |
| 117 | Hepatic necrosis (HP:0002605) | 2.00945977 |
| 118 | Palmoplantar keratoderma (HP:0000982) | 2.00295661 |
| 119 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.99806228 |
| 120 | Anencephaly (HP:0002323) | 1.99378774 |
| 121 | Broad metatarsal (HP:0001783) | 1.98491726 |
| 122 | Pachygyria (HP:0001302) | 1.97138879 |
| 123 | Progressive macrocephaly (HP:0004481) | 1.96759031 |
| 124 | Facial diplegia (HP:0001349) | 1.96625604 |
| 125 | Congenital hepatic fibrosis (HP:0002612) | 1.96337126 |
| 126 | Renal cortical cysts (HP:0000803) | 1.95452765 |
| 127 | Ketoacidosis (HP:0001993) | 1.94799338 |
| 128 | Concave nail (HP:0001598) | 1.94709069 |
| 129 | Dialeptic seizures (HP:0011146) | 1.94655332 |
| 130 | Decreased circulating renin level (HP:0003351) | 1.94466198 |
| 131 | Polyuria (HP:0000103) | 1.92865624 |
| 132 | Rapidly progressive (HP:0003678) | 1.91087912 |
| 133 | Bony spicule pigmentary retinopathy (HP:0007737) | 1.90685027 |
| 134 | Hepatocellular necrosis (HP:0001404) | 1.90508567 |
| 135 | Patellar aplasia (HP:0006443) | 1.89712145 |
| 136 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.89182033 |
| 137 | Rib fusion (HP:0000902) | 1.87573622 |
| 138 | Acute encephalopathy (HP:0006846) | 1.87527806 |
| 139 | Gait imbalance (HP:0002141) | 1.87007842 |
| 140 | Optic nerve hypoplasia (HP:0000609) | 1.86587194 |
| 141 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.86120480 |
| 142 | Furrowed tongue (HP:0000221) | 1.85572388 |
| 143 | Aplasia/Hypoplasia of the patella (HP:0006498) | 1.85362325 |
| 144 | Congenital sensorineural hearing impairment (HP:0008527) | 1.83945541 |
| 145 | Bulbous nose (HP:0000414) | 1.83304318 |
| 146 | Neuroendocrine neoplasm (HP:0100634) | 1.81834169 |
| 147 | Abnormality of the ischium (HP:0003174) | 1.81417647 |
| 148 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.81162370 |
| 149 | Dysmetric saccades (HP:0000641) | 1.80912784 |
| 150 | Mitochondrial inheritance (HP:0001427) | 1.80399033 |
| 151 | Calcaneovalgus deformity (HP:0001848) | 1.78227300 |
| 152 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.77527660 |
| 153 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.77523532 |
| 154 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 1.77386048 |
| 155 | Tachypnea (HP:0002789) | 1.77215793 |
| 156 | Exercise intolerance (HP:0003546) | 1.76316808 |
| 157 | Absent speech (HP:0001344) | 1.74925993 |
| 158 | Atonic seizures (HP:0010819) | 1.72998350 |
| 159 | Congenital, generalized hypertrichosis (HP:0004540) | 1.70459850 |
| 160 | Congestive heart failure (HP:0001635) | 1.68703518 |
| 161 | Epileptic encephalopathy (HP:0200134) | 1.68630153 |
| 162 | Absence seizures (HP:0002121) | 1.67862924 |
| 163 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.67560946 |
| 164 | Absent/shortened dynein arms (HP:0200106) | 1.67560946 |
| 165 | Hip contracture (HP:0003273) | 1.66980525 |
| 166 | Large for gestational age (HP:0001520) | 1.66095836 |
| 167 | Sudden cardiac death (HP:0001645) | 1.64269662 |
| 168 | Increased muscle lipid content (HP:0009058) | 1.64015273 |
| 169 | Bulbar palsy (HP:0001283) | 1.63696143 |
| 170 | Conjunctival hamartoma (HP:0100780) | 1.63607588 |
| 171 | Increased CSF lactate (HP:0002490) | 1.63308351 |
| 172 | Absent phalangeal crease (HP:0006109) | 1.61004313 |
| 173 | Hamartoma of the eye (HP:0010568) | 1.60544270 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TTN | 5.91225597 |
| 2 | FRK | 5.49014353 |
| 3 | OBSCN | 4.63929257 |
| 4 | PHKG2 | 4.56623331 |
| 5 | PHKG1 | 4.56623331 |
| 6 | DMPK | 2.95116342 |
| 7 | ADRBK2 | 2.85889521 |
| 8 | LMTK2 | 2.84609457 |
| 9 | TRIB3 | 2.55627537 |
| 10 | PDK3 | 2.55090381 |
| 11 | PDK4 | 2.55090381 |
| 12 | BMPR1B | 2.54079396 |
| 13 | MYLK | 2.48771476 |
| 14 | MARK1 | 2.38664454 |
| 15 | MUSK | 2.29454916 |
| 16 | CASK | 2.20524282 |
| 17 | GRK1 | 2.15180047 |
| 18 | PINK1 | 2.00814622 |
| 19 | PKN2 | 1.99209835 |
| 20 | ACVR1B | 1.99042658 |
| 21 | PIK3CA | 1.97083034 |
| 22 | NEK1 | 1.93045901 |
| 23 | WNK3 | 1.90123462 |
| 24 | MAPK13 | 1.81004796 |
| 25 | TIE1 | 1.72503741 |
| 26 | PDK2 | 1.71205470 |
| 27 | ZAK | 1.70813557 |
| 28 | NME1 | 1.62611512 |
| 29 | MAP3K7 | 1.45610290 |
| 30 | PAK3 | 1.45185330 |
| 31 | NUAK1 | 1.42869367 |
| 32 | MAP4K2 | 1.39992571 |
| 33 | EPHA4 | 1.39817885 |
| 34 | TLK1 | 1.38097054 |
| 35 | BCKDK | 1.37211632 |
| 36 | ADRBK1 | 1.36913655 |
| 37 | MAPK12 | 1.35731887 |
| 38 | PRKD3 | 1.22748372 |
| 39 | MAP2K3 | 1.22159446 |
| 40 | CAMK2D | 1.20519366 |
| 41 | PRKD1 | 1.12140822 |
| 42 | PRKCG | 1.10777527 |
| 43 | PTK2B | 1.10459717 |
| 44 | NTRK2 | 1.10175808 |
| 45 | GRK7 | 1.05948015 |
| 46 | PAK6 | 1.05798860 |
| 47 | OXSR1 | 1.05308999 |
| 48 | ILK | 1.04124476 |
| 49 | MAP2K4 | 1.03106656 |
| 50 | NTRK3 | 0.97483177 |
| 51 | MAPK15 | 0.97327023 |
| 52 | TAOK3 | 0.96680614 |
| 53 | PNCK | 0.95693975 |
| 54 | RIPK1 | 0.93481050 |
| 55 | WNK4 | 0.91868503 |
| 56 | KSR2 | 0.88339870 |
| 57 | STK24 | 0.86752452 |
| 58 | PDGFRA | 0.86491648 |
| 59 | ROCK1 | 0.86004602 |
| 60 | AKT3 | 0.85350262 |
| 61 | TGFBR1 | 0.85241800 |
| 62 | DAPK3 | 0.84093474 |
| 63 | DYRK2 | 0.81643580 |
| 64 | PKN1 | 0.81159475 |
| 65 | WNK1 | 0.80444442 |
| 66 | CAMK2A | 0.78378438 |
| 67 | ROCK2 | 0.75308972 |
| 68 | LATS2 | 0.74964622 |
| 69 | STK38 | 0.73902672 |
| 70 | STK39 | 0.73049469 |
| 71 | PRKAA1 | 0.70407515 |
| 72 | MAP3K4 | 0.70405966 |
| 73 | CAMK4 | 0.70034389 |
| 74 | TGFBR2 | 0.69680229 |
| 75 | DAPK2 | 0.69060804 |
| 76 | FER | 0.68817348 |
| 77 | CDC42BPA | 0.68001570 |
| 78 | PRKAA2 | 0.67558211 |
| 79 | PDPK1 | 0.66837084 |
| 80 | SGK2 | 0.65881229 |
| 81 | TNIK | 0.65599024 |
| 82 | FGFR2 | 0.65043093 |
| 83 | MKNK2 | 0.63948221 |
| 84 | CAMK1 | 0.63514966 |
| 85 | MAPKAPK3 | 0.63029303 |
| 86 | MAP3K5 | 0.62387415 |
| 87 | SGK223 | 0.62182300 |
| 88 | SGK494 | 0.62182300 |
| 89 | SIK2 | 0.62057245 |
| 90 | PIK3CG | 0.61660916 |
| 91 | LATS1 | 0.61439480 |
| 92 | MAP3K9 | 0.59837908 |
| 93 | CAMK2G | 0.59096908 |
| 94 | TXK | 0.58375501 |
| 95 | TRPM7 | 0.58087346 |
| 96 | ICK | 0.56961668 |
| 97 | PRKCH | 0.53306745 |
| 98 | PRKACB | 0.51909640 |
| 99 | RPS6KA6 | 0.51386096 |
| 100 | MAPKAPK5 | 0.51332738 |
| 101 | CAMKK2 | 0.51203026 |
| 102 | PRKCZ | 0.50177916 |
| 103 | PRKCI | 0.50003505 |
| 104 | MAP2K6 | 0.48082807 |
| 105 | PDK1 | 0.47467964 |
| 106 | CAMK1D | 0.46817658 |
| 107 | RET | 0.46454613 |
| 108 | PRKCE | 0.44699138 |
| 109 | EPHB1 | 0.44462851 |
| 110 | SGK1 | 0.43235967 |
| 111 | MAP3K1 | 0.41771228 |
| 112 | MAPK7 | 0.40493702 |
| 113 | ERBB2 | 0.40051692 |
| 114 | CAMK2B | 0.39722150 |
| 115 | KDR | 0.38753951 |
| 116 | CSNK1G2 | 0.37799179 |
| 117 | PLK2 | 0.37418190 |
| 118 | PRKCQ | 0.37233840 |
| 119 | PRKCA | 0.36550836 |
| 120 | STK11 | 0.35917804 |
| 121 | PRKACA | 0.35884809 |
| 122 | KSR1 | 0.35379636 |
| 123 | DDR2 | 0.35219403 |
| 124 | STK3 | 0.34552422 |
| 125 | LIMK1 | 0.33695227 |
| 126 | GRK5 | 0.33369486 |
| 127 | CAMKK1 | 0.33134699 |
| 128 | CSNK1D | 0.33032434 |
| 129 | AKT2 | 0.31228440 |
| 130 | CDK5 | 0.30671606 |
| 131 | INSRR | 0.30224221 |
| 132 | TAOK1 | 0.29761463 |
| 133 | RPS6KA3 | 0.29702752 |
| 134 | PRKG1 | 0.28624940 |
| 135 | MAP2K1 | 0.28481895 |
| 136 | PRKACG | 0.27888726 |
| 137 | STK38L | 0.25854764 |
| 138 | MARK2 | 0.25515189 |
| 139 | CAMK1G | 0.24093174 |
| 140 | SGK3 | 0.23916982 |
| 141 | MAP3K6 | 0.22716677 |
| 142 | MINK1 | 0.22164568 |
| 143 | EPHB2 | 0.21244588 |
| 144 | UHMK1 | 0.20154523 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 4.50545992 |
| 2 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 4.05641707 |
| 3 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 3.77070887 |
| 4 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 3.64784873 |
| 5 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.11307774 |
| 6 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 2.76358817 |
| 7 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.69042697 |
| 8 | Parkinsons disease_Homo sapiens_hsa05012 | 2.67993481 |
| 9 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.64473635 |
| 10 | Phototransduction_Homo sapiens_hsa04744 | 2.60072464 |
| 11 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.37534889 |
| 12 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.27440452 |
| 13 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 2.23120278 |
| 14 | Alzheimers disease_Homo sapiens_hsa05010 | 2.19508833 |
| 15 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.17993936 |
| 16 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 2.17670498 |
| 17 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.00323009 |
| 18 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.98089534 |
| 19 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.88386440 |
| 20 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.85087488 |
| 21 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.76142748 |
| 22 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.75160350 |
| 23 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.66873908 |
| 24 | Carbon metabolism_Homo sapiens_hsa01200 | 1.66274040 |
| 25 | Huntingtons disease_Homo sapiens_hsa05016 | 1.59271165 |
| 26 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.58736268 |
| 27 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.56613771 |
| 28 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.53488535 |
| 29 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.50873399 |
| 30 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.48810993 |
| 31 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.46281985 |
| 32 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.45024455 |
| 33 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.39403876 |
| 34 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.38918052 |
| 35 | Viral myocarditis_Homo sapiens_hsa05416 | 1.34515530 |
| 36 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.24123428 |
| 37 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.22981017 |
| 38 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.22709540 |
| 39 | ABC transporters_Homo sapiens_hsa02010 | 1.22398251 |
| 40 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.21852165 |
| 41 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.20468835 |
| 42 | Sulfur relay system_Homo sapiens_hsa04122 | 1.20356962 |
| 43 | Circadian entrainment_Homo sapiens_hsa04713 | 1.20343919 |
| 44 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.11449370 |
| 45 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.09746815 |
| 46 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.09498519 |
| 47 | Insulin secretion_Homo sapiens_hsa04911 | 1.08781148 |
| 48 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.07860710 |
| 49 | Renin secretion_Homo sapiens_hsa04924 | 1.06314884 |
| 50 | Olfactory transduction_Homo sapiens_hsa04740 | 1.06139491 |
| 51 | Insulin resistance_Homo sapiens_hsa04931 | 1.03359576 |
| 52 | Long-term potentiation_Homo sapiens_hsa04720 | 0.99060136 |
| 53 | Focal adhesion_Homo sapiens_hsa04510 | 0.97994731 |
| 54 | Histidine metabolism_Homo sapiens_hsa00340 | 0.97266006 |
| 55 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.95186595 |
| 56 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.93296200 |
| 57 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.93050307 |
| 58 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.91195640 |
| 59 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.89948361 |
| 60 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.88044251 |
| 61 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.87235423 |
| 62 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.87225721 |
| 63 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.86789565 |
| 64 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.86302834 |
| 65 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.84762864 |
| 66 | Tight junction_Homo sapiens_hsa04530 | 0.84513896 |
| 67 | Salivary secretion_Homo sapiens_hsa04970 | 0.83994772 |
| 68 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.83707620 |
| 69 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.83277016 |
| 70 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.81881071 |
| 71 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.81794890 |
| 72 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.77765855 |
| 73 | Circadian rhythm_Homo sapiens_hsa04710 | 0.77168333 |
| 74 | Gap junction_Homo sapiens_hsa04540 | 0.75388982 |
| 75 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.74747835 |
| 76 | Morphine addiction_Homo sapiens_hsa05032 | 0.74551312 |
| 77 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.74466903 |
| 78 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.72202906 |
| 79 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.72115221 |
| 80 | GABAergic synapse_Homo sapiens_hsa04727 | 0.70841421 |
| 81 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.69773845 |
| 82 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.69657064 |
| 83 | RNA polymerase_Homo sapiens_hsa03020 | 0.69173378 |
| 84 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.67914596 |
| 85 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.67862816 |
| 86 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.67778400 |
| 87 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.67251228 |
| 88 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.67166421 |
| 89 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.66677878 |
| 90 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.66252489 |
| 91 | Homologous recombination_Homo sapiens_hsa03440 | 0.65558507 |
| 92 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.64999857 |
| 93 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.64039569 |
| 94 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.63526895 |
| 95 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.63422559 |
| 96 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.62875641 |
| 97 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.62502879 |
| 98 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.61347630 |
| 99 | Basal transcription factors_Homo sapiens_hsa03022 | 0.61233413 |
| 100 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.60980716 |
| 101 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.60238144 |
| 102 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.60048956 |
| 103 | Melanogenesis_Homo sapiens_hsa04916 | 0.58166664 |
| 104 | Peroxisome_Homo sapiens_hsa04146 | 0.57861572 |
| 105 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.57770873 |
| 106 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.57697688 |
| 107 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.57446250 |
| 108 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.56322451 |
| 109 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.54034321 |
| 110 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.53309958 |
| 111 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.53124513 |
| 112 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.52810657 |
| 113 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.51915665 |
| 114 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.51043099 |
| 115 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.49790189 |
| 116 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.49598312 |
| 117 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.48733920 |
| 118 | Adherens junction_Homo sapiens_hsa04520 | 0.48513834 |
| 119 | Retinol metabolism_Homo sapiens_hsa00830 | 0.46603389 |
| 120 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.45870857 |
| 121 | Taste transduction_Homo sapiens_hsa04742 | 0.45396126 |
| 122 | Amoebiasis_Homo sapiens_hsa05146 | 0.45394214 |
| 123 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.45175761 |
| 124 | Glioma_Homo sapiens_hsa05214 | 0.43524603 |
| 125 | Bile secretion_Homo sapiens_hsa04976 | 0.42720003 |
| 126 | Axon guidance_Homo sapiens_hsa04360 | 0.42654009 |
| 127 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.42238928 |
| 128 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.41674842 |
| 129 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.41475848 |
| 130 | Mineral absorption_Homo sapiens_hsa04978 | 0.41045932 |
| 131 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.40884921 |
| 132 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.38969256 |
| 133 | Long-term depression_Homo sapiens_hsa04730 | 0.38793138 |
| 134 | Platelet activation_Homo sapiens_hsa04611 | 0.38688465 |
| 135 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.38573657 |
| 136 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.37990481 |
| 137 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.37459149 |
| 138 | Nicotine addiction_Homo sapiens_hsa05033 | 0.37111266 |
| 139 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.36792556 |
| 140 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.35565889 |
| 141 | Metabolic pathways_Homo sapiens_hsa01100 | 0.35518173 |
| 142 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.34493306 |
| 143 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.34475773 |
| 144 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.34249708 |
| 145 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.33646957 |
| 146 | Lysine degradation_Homo sapiens_hsa00310 | 0.32174985 |
| 147 | Cocaine addiction_Homo sapiens_hsa05030 | 0.29204767 |
| 148 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.28316282 |
| 149 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.27296060 |

